Evidence map›Paper›PMID 35731277›Full record

ArticleJournal of neurology2022

NMOSD typical brain lesions after COVID-19 mRNA vaccination.

Julie Lévi-Strauss, Corentin Provost, Noémie Wane, Thomas Jacquemont, Nicolas Mélé

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julie Lévi-StraussDepartment of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France. julie.levi.strauss@gmail.com.ORCID http://orcid.org/0000-0002-5827-5678
Corentin ProvostINSERM U1266, Institute of Psychiatry and Neuroscience of Paris, FHU NeuroVasc, Paris, France.
Noémie WaneDepartment of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France.
Thomas JacquemontDepartment of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France.
Nicolas MéléDepartment of Neurology, GHU Paris Psychiatrie et Neurosciences, Université Paris Cité, Sainte-Anne Hospital, 1 rue Cabanis, 75014, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Nervous System DiseasesNeuromyelitis OpticaAquaporin 4AutoantibodiesBrainHumansRNA, MessengerVaccinationAquaporin 4AutoantibodiesRNA, Messenger

Identifiers

PMID35731277
PMCPMC9214460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.